H1N1 Influenza A Vaccine (Split Virion)，Inactivated

甲型H1N1流感病毒裂解疫苗（Hard To Treat Diseases和浙江天元）

Report date: 2023/11/01 10:57:42

Base Information

Drug NameH1N1 Influenza A Vaccine (Split Virion)，Inactivated
Drug Alias NameSwine flu vaccine - Hard To Treat Diseases/Mellow Hope/Zhejiang Tianyuan Bio-pharmaceutical
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2009/09/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co LtdHard To Treat Diseases
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A